Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Urology|February 15, 2001
Human complement factor H related protein test for monitoring bladder cancerM P Raitanen, T Marttila, M Nurmi, et al.
Cancer Research|April 28, 2001
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancerM J Linja, K J Savinainen, O R Saramäki, et al.
Cancer Causes & Control : CCC|June 19, 2001
Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in FinlandM P Matikaine, E Pukkala, J Schleutker, et al.
The Journal of Urology|December 1, 1995
Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomyM Talja, T Tammela, A Petas, et al.
British Journal of Urology|January 24, 1998
Effects of biodegradable self-reinforced polyglycolic acid, poly-DL-lactic acid and stainless-steel spiral stents on uroepithelium after Nd:YAG laser irradiation of the canine prostateA Pétas, P Kärkkäinen, M Talja, et al.
Cancer Genetics and Cytogenetics|December 6, 2001
Chromosomal changes in locally recurrent, hormone-refractory prostate carcinomas by karyotyping and comparative genomic hybridizationK Haapala, A Rökman, C Palmberg, et al.
Anticancer Research|January 12, 2007
Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomyS Aaltomaa, V Kärjä, P Lipponen, et al.
Anticancer Research|December 13, 2005
Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancerS Aaltomaa, V Kärjä, P Lipponen, et al.
The Journal of Urology|June 1, 1992
Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound followupT L Tammela, P A Hellström, S I Mattila, et al.
The Journal of Urology|December 1, 1995
Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder GroupE Rintala, K Jauhiainen, P Rajala, et al.
Pageof 23